Parallax Volatility Advisers’s Royalty Pharma RPRX Stock Holding History

Parallax Volatility Advisers’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-370,200	Closed	-$13.1M	–	1806
2025 Q3	$13.1M	Hold	370,200	–	–	0.02%	392
2025 Q2	$13.3M	Hold	370,200	–	–	0.03%	351
2025 Q1	$11.5M	Buy	+370,200	New	+$11.7M	0.03%	420
2024 Q1	–	Sell	-160,000	Closed	-$4.49M	–	2273
2023 Q4	$4.49M	Hold	160,000	–	–	0.01%	863
2023 Q3	$4.34M	Buy	160,000 +60,000	+60%	+$1.78M	0.01%	811
2023 Q2	$3.07M	Buy	+100,000	New	+$3.39M	0.01%	965
2023 Q1	–	Sell	-20,000	Closed	-$790K	–	3114
2022 Q4	$790K	Hold	20,000	–	–	﹤0.01%	1738
2022 Q3	$804K	Buy	+20,000	New	+$854K	﹤0.01%	1808
2022 Q1	–	Sell	-180,000	Closed	-$7.17M	–	3114
2021 Q4	$7.17M	Sell	180,000 -50,200	-22%	-$1.95M	0.01%	700
2021 Q3	$8.32M	Buy	230,200 +180,000	+359%	+$7M	0.01%	701
2021 Q2	$2.06M	Buy	50,200 +200	+0.4%	+$8.51K	﹤0.01%	862
2021 Q1	$2.18M	Buy	+50,000	New	+$2.37M	﹤0.01%	669
2020 Q3	–	Sell	-35,600	Closed	-$1.73M	–	3150
2020 Q2	$1.73M	Buy	+35,600	New	+$1.76M	﹤0.01%	1528

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Parallax Volatility Advisers's RPRX Position: Q1 2026 in Review

Parallax Volatility Advisers sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 9,509 shares — an estimated $367K sold.

Parallax Volatility Advisers first reported a position in RPRX in Q2 2020 and held it in 3 quarters. The position peaked at $373K in Q2 2020. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

Parallax Volatility Advisers reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
Parallax Volatility Advisers sold 9,509 Royalty Pharma shares in Q1 2026, an estimated $367K.
Parallax Volatility Advisers first reported a position in Royalty Pharma in Q2 2020 and held it in 3 quarters.
Parallax Volatility Advisers's Royalty Pharma position peaked at $373K in Q2 2020.
587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.